Search Results

Research Collaboration with Amgen to Discover Small Molecule Therapeutics using Artificial Intelligence Novo Nordisk Invests 42 Billion Danish Kroner in New Manufacturing Facilities Addex ADX71149 Epilepsy Phase

May 2022 "We are thrilled to announce that our co-founder Margaux Duchamp has been selected as a 30 under

April 2022 John Streicher talks about his work on terpenes found in cannabis as these may be a novel

Biologics announce manufacturing agreement  to advance novel anti-CCR8 antibody  for cancer immunotherapy Novo

Therapeutics with Generative AI Nxera Pharma receives approval of insomnia drug in Japan Lilly and Novo and UK and Announces the Nomination of Clinical Candidate Against MC2 Call for GPCR Papers Deadline: Nov

31 December 2022 Addex Raises $5.0 Million in Equity Financing Testing the limits of SMILES-based de novo

De novo drug design: AI algorithms can generate new molecules with desired properties, such as binding

The research team, led by Brandon Novy and colleagues, utilized an innovative APEX2/AUR biosensor that

Mark:  “Have you found this to be accurate?” Beth:  “Yes.  Top candidates will have a solid foundation in GPCR pharmacology as well as some experience in drug discovery

Founded as a spinout from the University of Dundee on 20 July 2012, Exscientia pioneered the design of patients with advanced haematological cancers, international partnerships with pharma and healthcare foundations

modulation of isoform- and ligand specific aGPCR functions using unique tools, and thus establishes a foundation

In the experiment, similar sets of residues were found to be in significant contact with both ligands Our results build a strong foundation for further improvement of our approach by rationalizing the kinetics

While AlphaFold provides an excellent foundation for generating hypotheses in drug discovery, it is not

The right environment, paired with a supportive supervisor, laid the foundation for a fulfilling and Analyze Your Work as You Go The PhD journey is often compared to a rollercoaster, and I found this to

molecular determinants of ligand efficacy and potency in GPCR signalling, this research provides a foundation

Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with pioneer as co-founder The company's co-founder, GPCR pioneer and Nobel laureate Robert Lefkowitz, M.D., has 50 years of experience

protein-coupled receptors (GPCRs) and it participates in inflammatory and immune responses that have been found In vivo, we found that inhibition of GRP78-ATF6-CHOP apoptosis signaling improved ESS symptoms, and the This research further clarified the underlying role of β-arrestin2 and provided an experimental foundation

Hauser on receiving 4.8 mill DKK from Carlsberg Foundation’s Semper Ardens: Accelerate programme.

LSX World Congress Novel living yeast-based dual biosensor for detecting peptide variants The Galien Foundation

understanding of GPCR biased signaling induced by intracellular allosteric agonists and establish a strong foundation

Treat Dyskinesia and Other Movement Disorders with Tim Dyer Addex Therapeutics "Tim Dyer is the Co-Founder

The physical barrier this lipid bilayer creates is dynamic and interactive, becoming the foundation for

GPCR Founder Dr. Yamina Berchiche at the 3rd GPCRs Summit in Boston on March 5-7, 2024. Dr. GPCR Founder Dr.

shocked that I wasn’t asked if I was a student or a PI, I was more proud to say that I was coming as the founder I, in turn, recruited Yamina Berchiche, founder of DrGPCR.com, to join me in this endeavor.

Trial Assessing GTAEXS617 in Advanced Solid Tumours A Conversation with Murat Tunaboylu, Antiverse Co-Founder

Pharmaceuticals Announces $65 Million Private Placement Priced At-the-Market Andrew Hopkins, Exscientia’s founder

Our founder Dr. Yamina A.

Fast Company has named Exscientia as one of the Most Innovative Companies of 2023 Dirk Loeffert CEO & Founder